L3Harris chair Kubasik sells $10.8m in stock

L3Harris Technologies (LHX) reported strong Q2 2025 results, surpassing non-GAAP adjusted EPS of $2.78 and revenue of $5.43 billion, leading analysts like Bernstein and RBC Capital to raise price targets. The company further solidified its position with a $53.8 million U.S. DoD contract modification and a strategic partnership with Joby Aviation to develop a hybrid aircraft for defense applications. Amidst this positive momentum, including a 36% stock gain over six months and 23 consecutive years of dividend increases, CEO Christopher E. Kubasik executed a planned transaction on August 11, 2025, selling 40,138 shares for approximately $10.8 million while simultaneously exercising options for an equivalent number of shares.

Analysis

L3Harris Technologies (LHX) is displaying strong operational and market momentum, underpinned by a significant second-quarter 2025 earnings beat, where non-GAAP adjusted EPS of $2.78 surpassed the $2.49 consensus estimate on revenues of $5.43 billion, which also exceeded expectations. This robust performance has prompted positive analyst revisions, with Bernstein raising its price target to $324 and RBC Capital increasing its target to $280. The company's growth trajectory is further supported by new business, including a $53.8 million contract modification from the U.S. Department of Defense and a strategic collaboration with Joby Aviation to develop a hybrid defense aircraft. The CEO's recent transaction, involving the sale of 40,138 shares for approximately $10.8 million, was executed concurrently with the exercise of options for an identical number of shares at a strike price of $149.31. This structure is common for covering exercise costs and taxes and is less indicative of a negative outlook, especially as the CEO retains a direct stake of over 145,000 shares. The stock's 36% gain over the past six months is complemented by strong fundamentals, including 23 consecutive years of dividend increases, and an external analysis suggesting the stock is trading slightly below its fair value.

Key Decisions for Investors

• Given the strong Q2 2025 earnings beat, positive analyst price target revisions, and new contract wins, investors may view the stock's recent momentum as fundamentally supported with potential for further upside toward the $324 analyst high.
• The CEO's stock sale should be viewed in the context of a simultaneous option exercise, a common cashless transaction for executives, rather than as a bearish signal on the company's future prospects.
• Key catalysts to monitor include the successful execution of the Joby Aviation partnership and additional defense contract awards, which are critical for justifying the stock's performance and achieving higher valuation targets.